Brief: Replimune Group, Inc. Files For Mixed Shelf Size Not Disclosed
Brief: Replimune Reports Fiscal First Quarter 2027 Financial Results And Provides Corporate Update
Replimune Q1 net loss narrows as expenses decline
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
Replimune jumps after $150 mln equity offering for skin cancer drug
U.S. STOCKS ON THE MOVE-SpaceX, Federal Realty, Celsius Holdings
Replimune slides as FDA approval label tempers enthusiasm
U.S. STOCKS ON THE MOVE-Atlassian, Macerich, DoubleVerify
Replimune slides as FDA approval label tempers enthusiasm
US FDA approves Replimune's skin cancer drug after prior rejections (updated)
US FDA approves Replimune's skin cancer drug
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. STOCKS ON THE MOVE-GoDaddy, Amazon, Chevron
U.S. STOCKS ON THE MOVE-Apple, Reddit, Roblox
Replimune more than doubles after FDA panel backs skin cancer drug
U.S. STOCKS ON THE MOVE-Amazon, Monolithic Power Systems, Eaton Corp
Replimune surges after FDA panel votes in favor of skin cancer drug
Replimune surges after FDA advisers back skin cancer drug
NASDAQ RESUMED AT 07:50 PM